VAISHALI PHARMA
Back to Income Statement
|
VAISHALI PHARMA Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹70 Cr | ₹76 Cr | ₹5,377,389 Cr | ₹60 Cr | ₹75 Cr |
What is the latest Revenue of VAISHALI PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹70 Cr |
Mar2023 | ₹76 Cr |
Mar2022 | ₹5,377,389 Cr |
Mar2021 | ₹60 Cr |
Mar2020 | ₹75 Cr |
How is Revenue of VAISHALI PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹70 Cr | -8.12 | |
Mar2023 | ₹76 Cr | -100.00 | |
Mar2022 | ₹5,377,389 Cr | 8,949,387.00 | |
Mar2021 | ₹60 Cr | -19.98 | |
Mar2020 | ₹75 Cr | - |
Compare Revenue of peers of VAISHALI PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VAISHALI PHARMA | ₹162.7 Cr | -1.3% | -3.9% | -18.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
VAISHALI PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VAISHALI PHARMA | -1.3% |
-3.9% |
-18.4% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses